Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study

Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study

Objective: To evaluate the risk of venous thromboembolism (VTE) with tofacitinib compared with TNFis in patients with RA. Methods: RA patients initiating tofacitinib or a TNFi without use of any biologic or tofacitinib any time prior were identified from IBM 'MarketScan' (2012-18), Medicar...

Full description

Bibliographic Details
Main Authors: Desai, R.J (Author), Khosrow-Khavar, F. (Author), Kim, S.C (Author), Pawar, A. (Author), Weinblatt, M.E (Author)
Format: Article
Language:English
Published: Oxford University Press 2022
Subjects:
Arthritis, Rheumatoid
cohort analysis
Cohort Studies
human
Humans
Janus kinase inhibitor
Janus Kinase inhibitors
Janus Kinase Inhibitors
meta analysis
piperidine derivative
Piperidines
pyrimidine derivative
Pyrimidines
rheumatoid arthritis
safety
tofacitinib
venous thromboembolism
Venous Thromboembolism
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items